ezogabine has been researched along with Acute Brain Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, C; Gao, R; Guo, J; He, Z; Qin, C; Ren, J; Wang, Q; Wang, Z; Zang, L; Zhao, C; Zhu, S | 1 |
| Feng, XM; Li, GB; Liu, JY; Zhang, BL; Zhang, RS | 1 |
2 other study(ies) available for ezogabine and Acute Brain Injuries
| Article | Year |
|---|---|
The Role of Potassium Channels in Chronic Stress-Induced Brain Injury.
Topics: Animals; Brain; Brain Injuries; Carbamates; Disease Models, Animal; Female; Humans; Neuroprotective Agents; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Rats; RNA-Seq; Signal Transduction; Stress, Psychological | 2021 |
Retigabine attenuates focal cerebral ischemic injury through inhibiting mitochondria-dependent apoptotic pathway.
Topics: Animals; Apoptosis; Brain Injuries; Carbamates; Caspase 3; Disease Models, Animal; Glutathione; JNK Mitogen-Activated Protein Kinases; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mitochondria; Oxidative Stress; Phenylenediamines; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Superoxide Dismutase | 2018 |